These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

762 related items for PubMed ID: 16216365

  • 1. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
    Nickers P, Thissen B, Jansen N, Deneufbourg JM.
    Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
    [Abstract] [Full Text] [Related]

  • 2. Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system?
    Nickers P, Lenaerts E, Thissen B, Deneufbourg JM.
    Radiother Oncol; 2005 Feb; 74(2):131-6. PubMed ID: 15734200
    [Abstract] [Full Text] [Related]

  • 3. 192Ir low dose rate brachytherapy for boosting locally advanced prostate cancers after external beam radiotherapy: a phase II trial.
    Nickers P, Coppens L, de Leval J, Jansen N, Deneufbourg JM.
    Radiother Oncol; 2006 Jun; 79(3):329-34. PubMed ID: 16780976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS, Martinez AA, Hollander M, Huang R, Goldman K, Chen PY, Gustafson GS.
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [Abstract] [Full Text] [Related]

  • 6. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
    Pinkawa M, Fischedick K, Treusacher P, Asadpour B, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ.
    Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
    Fang FM, Wang YM, Wang CJ, Huang HY, Chiang PH.
    Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
    [Abstract] [Full Text] [Related]

  • 9. [Advances in brachytherapy--focusing on the permanent implant for early prostate carcinoma].
    Hirokawa Y.
    Gan To Kagaku Ryoho; 2003 Dec; 30(13):2056-61. PubMed ID: 14712765
    [Abstract] [Full Text] [Related]

  • 10. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B, Pouliot J.
    Med Dosim; 2004 Dec; 29(3):204-9. PubMed ID: 15324917
    [Abstract] [Full Text] [Related]

  • 11. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D, Weinberg V, Cunha JA, Hsu IC, Pouliot J.
    Brachytherapy; 2011 Dec; 10(6):461-5. PubMed ID: 21397569
    [Abstract] [Full Text] [Related]

  • 12. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S.
    Brachytherapy; 2008 Dec; 7(4):336-42. PubMed ID: 18782683
    [Abstract] [Full Text] [Related]

  • 13. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT, Yuen J, D'Souza DP, Batchelar DL.
    Brachytherapy; 2008 Dec; 7(1):37-42. PubMed ID: 18299111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Brachytherapy boost irradiation in the treatment of high risk, localised prostate cancer. Initial national experience in Hungary].
    Agoston P, Major T, Somogyi A, Szûcs M, Danczig A, Lövey J, Polgár C, Fodor J, Németh G, Kásler M.
    Magy Onkol; 2004 Dec; 48(1):81-8. PubMed ID: 15105901
    [Abstract] [Full Text] [Related]

  • 18. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications.
    Zelefsky MJ, Yamada Y, Cohen GN, Sharma N, Shippy AM, Fridman D, Zaider M.
    Radiother Oncol; 2007 Aug; 84(2):185-9. PubMed ID: 17692978
    [Abstract] [Full Text] [Related]

  • 19. Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer.
    Pellizzon AC, Salvajoli JV, Maia MA, Ferrigno R, Novaes PE, Fogarolli RC, Pellizzon RJ.
    J Urol; 2004 Mar; 171(3):1105-8. PubMed ID: 14767280
    [Abstract] [Full Text] [Related]

  • 20. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.
    Pouliot J, Kim Y, Lessard E, Hsu IC, Vigneron DB, Kurhanewicz J.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1196-207. PubMed ID: 15234056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.